Charles Schwab Investment Management Inc Bio Xcel Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.14 - $2.97 $14,415 - $37,555	12,645 Added 6.62%	203,615 $260,000
Q1 2024 May 08, 2024	BUY	$1.95 - $4.04 $6,747 - $13,978	3,460 Added 1.85%	190,970 $538,000
Q4 2023 Feb 06, 2024	BUY	$2.32 - $5.51 $117,640 - $279,395	50,707 Added 37.07%	187,510 $553,000
Q3 2023 Nov 08, 2023	SELL	$2.49 - $11.85 $28,313 - $134,746	-11,371 Reduced 7.67%	136,803 $346,000
Q2 2023 Aug 09, 2023	BUY	$6.39 - $28.58 $27,355 - $122,350	4,281 Added 2.98%	148,174 $986,000
Q1 2023 May 11, 2023	BUY	$17.7 - $33.24 $10,814 - $20,309	611 Added 0.43%	143,893 $2.69 Million
Q4 2022 Feb 13, 2023	BUY	$10.25 - $22.43 $28,587 - $62,557	2,789 Added 1.99%	143,282 $3.08 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $171,811 - $274,683	15,354 Added 12.27%	140,493 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$9.03 - $21.55 $91,844 - $219,185	-10,171 Reduced 7.52%	125,139 $1.65 Million
Q1 2022 May 13, 2022	BUY	$15.0 - $22.83 $54,030 - $82,233	3,602 Added 2.73%	135,310 $2.83 Million
Q4 2021 Feb 11, 2022	BUY	$20.12 - $35.09 $35,089 - $61,196	1,744 Added 1.34%	131,708 $2.68 Million
Q3 2021 Nov 16, 2021	BUY	$23.84 - $32.03 $648,924 - $871,856	27,220 Added 26.49%	129,964 $3.95 Million
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $195,370 - $261,054	6,723 Added 7.0%	102,744 $2.99 Million
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $93,813 - $155,233	2,403 Added 2.57%	96,021 $4.15 Million
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $116,467 - $155,198	2,743 Added 3.02%	93,618 $4.33 Million
Q3 2020 Nov 13, 2020	BUY	$37.44 - $64.63 $2.41 Million - $4.17 Million	64,453 Added 243.94%	90,875 $3.94 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $197,167 - $656,964	11,190 Added 73.46%	26,422 $1.4 Million
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $1,716 - $5,759	140 Added 0.93%	15,232 $341,000
Q4 2019 Feb 07, 2020	BUY	$4.05 - $14.61 $10,351 - $37,343	2,556 Added 20.39%	15,092 $221,000
Q2 2019 Aug 09, 2019	BUY	$8.99 - $11.79 $112,698 - $147,799	12,536 New	12,536 $138,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account